Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis (original) (raw)

You do not currently have access to this article.

Purchase

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis - 24 Hours access

EUR €58.00

GBP £50.00

USD $62.00

This article is also available for rental through DeepDyve.

Advertisement intended for healthcare professionals